BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 23924605)

  • 1. The role of brain noradrenergic system in the regulation of liver cytochrome P450 expression.
    Sadakierska-Chudy A; Haduch A; Rysz M; Gołembiowska K; Daniel WA
    Biochem Pharmacol; 2013 Sep; 86(6):800-7. PubMed ID: 23924605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the paraventricular (PVN) and arcuate (ARC) nuclei of the hypothalamus in the central noradrenergic regulation of liver cytochrome P450.
    Bromek E; Wójcikowski J; Daniel WA
    Biochem Pharmacol; 2013 Dec; 86(11):1614-20. PubMed ID: 24051135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 is regulated by noradrenergic and serotonergic systems.
    Kot M; Daniel WA
    Pharmacol Res; 2011 Oct; 64(4):371-80. PubMed ID: 21742037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the dorsal noradrenergic pathway of the brain (locus coeruleus) in the regulation of liver cytochrome P450 activity.
    Kot M; Sadakierska-Chudy A; Haduch A; Rysz M; Bromek E; Gołembiowska K; Daniel WA
    Eur J Pharmacol; 2015 Mar; 751():34-41. PubMed ID: 25637782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Damage to the Brain Serotonergic System Increases the Expression of Liver Cytochrome P450.
    Rysz M; Bromek E; Haduch A; Sadakierska-Chudy A; Daniel WA
    Drug Metab Dispos; 2015 Sep; 43(9):1345-52. PubMed ID: 26059263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of brain serotonergic system by repeated intracerebral administration of 5-hydroxytryptophan (5-HTP) decreases the expression and activity of liver cytochrome P450.
    Rysz M; Bromek E; Daniel WA
    Biochem Pharmacol; 2016 Jan; 99():113-22. PubMed ID: 26581122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nuclear receptors pregnane X receptor and constitutive androstane receptor contribute to the impact of fipronil on hepatic gene expression linked to thyroid hormone metabolism.
    Roques BB; Leghait J; Lacroix MZ; Lasserre F; Pineau T; Viguié C; Martin PG
    Biochem Pharmacol; 2013 Oct; 86(7):997-1039. PubMed ID: 23962444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of liver cytochrome P450 by activation of brain dopaminergic system: physiological and pharmacological implications.
    Wójcikowski J; Gołembiowska K; Daniel WA
    Biochem Pharmacol; 2008 Jul; 76(2):258-67. PubMed ID: 18538745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The brain dopaminergic system as an important center regulating liver cytochrome P450 in the rat.
    Wójcikowski J; Daniel WA
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):631-45. PubMed ID: 19442036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of endobiotic-oxidizing cytochromes P450 in vitamin A-deficient male rat liver.
    Murray M; Sefton RM; Croft KD; Butler AM
    Br J Pharmacol; 2001 Dec; 134(7):1487-97. PubMed ID: 11724755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous alterations of brain and plasma serotonin concentrations and liver cytochrome P450 in rats fed on a tryptophan-free diet.
    Kot M; Pilc A; Daniel WA
    Pharmacol Res; 2012 Oct; 66(4):292-9. PubMed ID: 22749902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Influence of Long-Term Treatment with Asenapine on Liver Cytochrome P450 Expression and Activity in the Rat. The Involvement of Different Mechanisms.
    Danek PJ; Bromek E; Daniel WA
    Pharmaceuticals (Basel); 2021 Jun; 14(7):. PubMed ID: 34209648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin Receptors of 5-HT
    Bromek E; Rysz M; Haduch A; Daniel WA
    Drug Metab Dispos; 2019 Feb; 47(2):80-85. PubMed ID: 30518657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of noradrenergic neurotoxin DSP-4 and noradrenaline transporter knockout (NET-KO) on the activity of liver cytochrome P450 3A (CYP3A) in male and female mice.
    Bromek E; Danek PJ; Wójcikowski J; Basińska-Ziobroń A; Pukło R; Solich J; Dziedzicka-Wasylewska M; Daniel WA
    Pharmacol Rep; 2022 Oct; 74(5):1107-1114. PubMed ID: 36018449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of constitutive mouse hepatic cytochromes P450 and growth hormone signaling components by 3-methylcholanthrene.
    Lee C; Hutson JR; Tzau VK; Riddick DS
    Drug Metab Dispos; 2006 Sep; 34(9):1530-8. PubMed ID: 16782765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the nervous system in the regulation of liver cytochrome p450.
    Wójcikowski J; Daniel WA
    Curr Drug Metab; 2011 Feb; 12(2):124-38. PubMed ID: 21401511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of factors mediating the effect of the brain dopaminergic system on the expression of cytochrome P450 in the liver.
    Wójcikowski J; Daniel WA
    Pharmacol Rep; 2008; 60(6):966-71. PubMed ID: 19211990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of hepatic CYP3A1/2 and CYP2C11 by cyclosporine is not mediated by altering growth hormone levels.
    Lu SK; Callahan SM; Brunner LJ
    J Pharmacol Exp Ther; 2003 Apr; 305(1):331-7. PubMed ID: 12649386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reverse role of the hypothalamic paraventricular (PVN) and arcuate (ARC) nuclei in the central serotonergic regulation of the liver cytochrome P450 isoform CYP2C11.
    Rysz M; Bromek E; Haduch A; Liskova B; Wójcikowski J; Daniel WA
    Biochem Pharmacol; 2016 Jul; 112():82-9. PubMed ID: 27137992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Chronic Iloperidone Treatment on Cytochrome P450 Expression and Activity in the Rat Liver: Involvement of Neuroendocrine Mechanisms.
    Danek PJ; Kuban W; Daniel WA
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.